Clinical Topics & News

Oral Therapies for Psoriasis: Report From the AAD Meeting

Publish date: August 8, 2016
By
Gary Goldenberg, MD
Author and Disclosure Information

 

Patients with psoriasis now have several treatment options to help control their disease. Among them are oral therapies. Dr. Gary Goldenberg reviews clearance data on approved therapies and ones on the horizon.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Brodalumab approval recommended, despite possible suicide signal
MDedge Dermatology
Psoriatic arthritis patients have elevated risk for coronary artery plaque
MDedge Dermatology
Psoriasiform eruptions in Kawasaki disease reveal distinct phenotype
MDedge Dermatology
Benefits, challenges emerge in evolution of rheumatology-dermatology clinics
MDedge Dermatology
Weight loss boosts TNFi’s psoriatic arthritis efficacy
MDedge Dermatology
Psoriatic arthritis patients face more endocrine comorbidities
MDedge Dermatology
Psoriatic flare assessment tool in validation stage
MDedge Dermatology
Ultrasound’s role in detecting enthesitis in psoriatic arthritis remains debatable
MDedge Dermatology
Skin microbiome may differ in unique ways in psoriatic arthritis, psoriasis patients
MDedge Dermatology
Shining a light on nonplaque psoriasis
MDedge Dermatology